VIB researchers from UGent and Vrije Universiteit Brussel , together with a team of the firm Oxyrane have developed a new technology that can lead to a more efficient and possibly also cheaper therapy for diseases such as Pompe disease. Oxyrane will now start developing a clinical program for...
On average, new treatments perform better in clinical trials only slightly more often than existing treatments, according to a new systematic review published in The Cochrane Library. The fact that experimental treatments are not more effective may seem disappointing, but the authors of the...
Allergan, Inc. (NYSE: AGN) announced the United States Food and Drug Administration (FDA) has approved BOTOX® (onabotulinumtoxinA) for the prophylactic (preventive) treatment of headaches in adults with Chronic Migraine,1 a distinct and severe neurological disorder characterized by patients who...
UroToday.com - Radical cystectomy is the most effective treatment for patients with organ confined muscle invasive or recurrent high grade non muscle invasive bladder cancer. Although minimally invasive techniques are being increasingly applied to the adrenal gland and upper urinary tract...
In connection with the New York Times' recent coverage of hormone therapy1, Pfizer Inc. released important facts and context to respond to the newspaper's account. Pfizer believes the coverage is based on a misleading and selective reading of both the science and history of hormone therapy (HT)...